Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

7.00
Delayed Data
As of 3:59pm ET
 +0.08 / +1.16%
Today’s Change
6.60
Today|||52-Week Range
10.32
-28.57%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close6.92
Today’s open6.96
Day’s range6.92 - 7.26
Volume37,659
Average volume (3 months)52,638
Market cap$157.6M
Dividend yield--
Data as of 3:59pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-25.93%
Earnings growth (next 5 years)+24.61%
Revenue growth (last year)+6.98%
P/E ratio--
Price/Sales4.53
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
GNCAGenocea Biosciences ...+0.17+3.07%
OSIROsiris Therapeutics ...+0.03+0.64%
EVGNEvogene Ltd+0.06+0.92%
ADVMAdverum Biotechnolog...+0.19+4.73%
Data as of 3:59pm ET, 09/27/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)$0.07
Annual revenue (last year)$50.4M
Annual profit (last year)$6.7M
Net profit margin13.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ariel Katz
Chief Financial Officer &
Vice President
Oren Bryan
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts

Search for Jobs